Discovery of novel NLRP3 inhibitors enabled by a high-throughput screen

被引:0
|
作者
Dorich, Stephane [1 ]
Auger, Anick [1 ]
Wang, Li [2 ]
Burch, Jason [1 ]
Pellerin, Charles [1 ]
Chan, Silas [2 ]
Raymond, Marianne [1 ]
Zhang, Lingling [2 ]
Chefson, Amandine [1 ]
Germain, Marie-Anne [1 ]
Jananji, Silvana [1 ]
Dumais, Valerie [1 ]
Gaudreault, Samuel [1 ]
Caron, Alexandre [1 ]
Dumas-Berube, Emilie [1 ]
Crackower, Michael. A. [2 ]
机构
[1] Ventus Therapeut Inc, 4800 Rue Levy, St Laurent, PQ H4R 2P1, Canada
[2] Ventus Therapeut US Inc, 100 Beaver St,Suite 201, Waltham, MA 02453 USA
关键词
NLRP3; inhibitors; High-throughput screen (HTS); Scintillation proximity assay (SPA); Brain penetrant; Furan; Pharmacodynamic model; INFLAMMASOME;
D O I
10.1016/j.bmcl.2025.130184
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
NLRP3 is a key regulator of the innate immune system involved in sensing a variety of pathogen and danger signals. Priming and activation of NLRP3 leads to the release and maturation of pro-inflammatory cytokines, as well as gasdermin D-mediated cell death. Inhibition of dysregulated NLRP3 activity has been associated with promising therapeutic opportunities for a variety of systemic and neurological diseases including atherosclerosis and Parkinson's disease. Herein, we discuss how a high-throughput screen (HTS) allowed us to discover new chemical scaffolds that specifically bind to NLRP3 and inhibit its function in a selective manner. We also describe how an enantiomer of HTS hit 5, compound 11, demonstrated in vivo inhibition of NLRP3.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors
    Goglia, Alexander G.
    Delsite, Robert
    Luz, Antonio N.
    Shahbazian, David
    Salem, Ahmed F.
    Sundaram, Ranjini K.
    Chiaravalli, Jeanne
    Hendrikx, Petrus J.
    Wilshire, Jennifer A.
    Jasin, Maria
    Kluger, Harriet M.
    Glickman, J. Fraser
    Powell, Simon N.
    Bindra, Ranjit S.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 326 - 342
  • [42] Label-free high-throughput assays to screen and characterize novel lactate dehydrogenase inhibitors
    VanderPorten, Erica
    Frick, Lauren
    Turincio, Rebecca
    Thana, Peter
    LaMarr, William
    Liu, Yichin
    ANALYTICAL BIOCHEMISTRY, 2013, 441 (02) : 115 - 122
  • [43] Development of a novel high-throughput screen for the identification of new inhibitors of protein S-acylation
    Salaun, Christine
    Takizawa, Hiroya
    Galindo, Alex
    Munro, Kevin R.
    McLellan, Jayde
    Sugimoto, Isamu
    Okino, Tomotaka
    Tomkinson, Nicholas C. O.
    Chamberlain, Luke H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (10)
  • [44] Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors
    Harrison, David
    Boutard, Nicolas
    Brzozka, Krzysztof
    Bugaj, Marta
    Chmielewski, Stefan
    Cierpich, Anna
    Doedens, John R.
    Fabritius, Charles-Henry R. Y.
    Gabel, Christopher A.
    Galezowski, Michal
    Kowalczyk, Piotr
    Levenets, Oleksandr
    Mroczkowska, Magdalena
    Palica, Katarzyna
    Porter, Roderick A.
    Schultz, David
    Sowinska, Marta
    Topolnicki, Grzegorz
    Urbanski, Piotr
    Woyciechowski, Jakub
    Watt, Alan P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (23)
  • [45] A high-throughput digital imaging screen for the discovery and directed evolution of oxygenases
    Joo, H
    Arisawa, A
    Lin, ZL
    Arnold, FH
    CHEMISTRY & BIOLOGY, 1999, 6 (10): : 699 - 706
  • [46] DEVELOPMENT OF A HIGH-THROUGHPUT SCREEN FOR THE DISCOVERY OF TMEM16A MODULATORS
    Liu, E.
    Lauffer, D.
    David, S.
    Deshpande, A.
    Sui, J.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 259 - 259
  • [47] Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors
    Bock, Mark G.
    Doedens, John R.
    Gabel, Christopher A.
    Holloway, M. Katharine
    Lewis, Arwel
    Scanlon, Jane
    Sharpe, Andrew
    Simpson, Iain D.
    Smolak, Pamela
    Wishart, Grant
    Watt, Alan P.
    Harrison, David
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1321 - 1328
  • [48] Mash Screen: high-throughput sequence containment estimation for genome discovery
    Brian D. Ondov
    Gabriel J. Starrett
    Anna Sappington
    Aleksandra Kostic
    Sergey Koren
    Christopher B. Buck
    Adam M. Phillippy
    Genome Biology, 20
  • [49] Mash Screen: high-throughput sequence containment estimation for genome discovery
    Ondov, Brian D.
    Starrett, Gabriel J.
    Sappington, Anna
    Kostic, Aleksandra
    Koren, Sergey
    Buck, Christopher B.
    Phillippy, Adam M.
    GENOME BIOLOGY, 2019, 20 (01)
  • [50] A high-throughput multivariate statistics platform for the discovery of tyrosinase inhibitors
    Boka, V., I
    Vontzalidou, A.
    Stathopoulou, K.
    Cheilari, A.
    Benaki, D.
    Gikas, E.
    Mikros, E.
    Aligiannis, N.
    PLANTA MEDICA, 2019, 85 (18) : 1459 - 1459